文献速递皮肤肿瘤

黑色素瘤手术治疗延迟与总死亡率和黑色素瘤特异性死亡率恶化相关:一项基于人群的分析

Delays in the surgical treatment of melanoma are associated with worsened overall and melanoma-specific mortality: A population-based analysis.
PubMed 文献 · J Am Acad Dermatol · 2022-07-01

基于监测、流行病学和最终结果数据库(N=108,689)的I至III期皮肤黑色素瘤患者分析显示,手术治疗延迟3至5个月与更差的黑色素瘤特异性死亡率相关,任何超过1个月的延迟与更差的总死亡率相关;I期亚组结果类似,II期延迟6个月以上与更差黑色素瘤特异性死亡率相关,III期未见显著影响。

要点

  • 所有分期中,手术延迟3至5个月与更差的黑色素瘤特异性死亡率相关。
  • 所有分期中,任何超过1个月的手术延迟与更差的总死亡率相关。
  • III期黑色素瘤患者中未观察到手术延迟的显著影响。

核心结论

  • 及时治疗黑色素瘤可能与改善总死亡率和黑色素瘤特异性死亡率相关。

研究设计与样本

  • 通过监测、流行病学和最终结果数据库识别I至III期皮肤黑色素瘤患者,共108,689例,纳入病例具有从诊断到确定性手术的时间和随访时间。
  • 采用Cox比例风险模型和Fine-Gray竞争风险分析评估治疗延迟对死亡率的影响。

主要发现

  • 所有分期中,手术延迟3至5个月与更差的黑色素瘤特异性死亡率相关,任何超过1个月的延迟与更差的总死亡率相关。
  • I期疾病亚组分析中,延迟3至5个月与更差的黑色素瘤特异性死亡率相关,任何超过1个月的延迟与更差的总死亡率相关。
  • II期疾病患者中,延迟6个月以上与更差的黑色素瘤特异性死亡率相关,延迟3至5个月与更差的总死亡率相关。
  • III期疾病中未观察到治疗延迟的显著影响。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 监测、流行病学和最终结果数据库未收集辅助治疗、疾病复发或治疗失败的全面数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The effect of treatment delays on melanoma outcomes remains unclear. OBJECTIVE: To assess the impact of surgical treatment delays on melanoma-specific mortality (MSM) and overall mortality (OM). METHODS: Patients with stage I to III cutaneous melanoma were identified through the Surveillance, Epidemiology, and End Results database (N = 108,689). Included cases had time from diagnosis to definitive surgery and follow-up time. Cox proportional hazards and Fine-Gray competing risks analyses were used to assess the impact of treatment delays on mortality. RESULTS: Across all stages, treatment delays of 3 to 5 months were associated with worse MSM and any delay beyond 1 month was associated with worse OM. In a subgroup analysis of patients with stage I disease, delays of 3 to 5 months were associated with worse MSM and any delay beyond 1 month was associated with worse OM. In patients with stage II disease, worse MSM was found with delays of 6+ months and worse OM was seen with delays of 3 to 5 months. No significant effect of treatment delays was noted in stage III disease. LIMITATIONS: The Surveillance, Epidemiology, and End Results database does not collect comprehensive data on adjuvant treatments, disease recurrence, or treatment failure. CONCLUSION: Timely treatment of melanoma may be associated with improved OM and MSM.

来源:J Am Acad Dermatol,查看原文。版权归原作者所有。

引用

  1. Xiong DD, Barriera-Silvestrini P, Knackstedt TJ, et al. Delays in the surgical treatment of melanoma are associated with worsened overall and melanoma-specific mortality: A population-based analysis. J Am Acad Dermatol. 2022. PMID: 35787410. doi:10.1016/j.jaad.2022.06.1190

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。